Atossa Therapeutics
ATOS
#9257
Rank
HK$0.78 B
Marketcap
HK$6.08
Share price
-2.21%
Change (1 day)
-37.47%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -HK$1.80

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.79. In 2024 the company made an earnings per share (EPS) of -HK$1.56 an increase over its 2023 EPS that were of -HK$1.87.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.8015.38%
2024-HK$1.56-16.67%
2023-HK$1.8714.29%
2022-HK$1.6316.67%
2021-HK$1.40-90.86%
2020-HK$15.33-2.96%
2019-HK$15.79-63.09%
2018-HK$42.79-49.63%
2017-HK$84.96-57.87%
2016-HK$201.66-74.01%
2015-HK$775.84-9.18%
2014-HK$854.27-12.86%
2013-HK$980.3070.73%
2012-HK$574.1834.08%
2011-HK$428.24263.47%
2010-HK$117.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.22-4,638.87%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$79.75-4,556.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$67.22-3,856.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.63-8.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$6.85 282.61%๐Ÿ‡บ๐Ÿ‡ธ USA